Nasdaq · Healthcare
NATURES SUNSHINE PRODUCTS INC (NATR)
As-reported financials and recent SEC filings for NATURES SUNSHINE PRODUCTS INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$480.1M
Net income
$19.5M
Net margin
4.1%
Diluted EPS
$1.06
ROE
12.1%
P/E (TTM)
19.1×
Market cap
$369.6M
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2023 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $480.1M | $454.4M | $445.3M | $421.9M | $444.1M |
| Gross profit | $347.7M | $324.7M | $321.1M | $299.8M | $328.6M |
| Operating income | $24.7M | $20.1M | $18.7M | $16.3M | $34.7M |
| Net income | $19.5M | $7.7M | $15.1M | $-390,000 | $30.2M |
| Diluted EPS | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-15
View on EDGAR →42026-06-11
View on EDGAR →42026-06-03
View on EDGAR →42026-05-22
View on EDGAR →42026-05-20
View on EDGAR →42026-05-19
View on EDGAR →42026-05-19
View on EDGAR →42026-05-19
View on EDGAR →Go deeper on NATR
Search NATURES SUNSHINE PRODUCTS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.